Burzynski Research Institute, Inc. (BZYR)

Market Cap	1.14M -75.1%
Revenue (ttm)	n/a
Net Income	-1.29M
EPS	-0.01
Shares Out	131.45M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.0050
Previous Close	0.0050
Day's Range	0.0045 - 0.0090
52-Week Range	0.0040 - 0.0470
Beta	0.41
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 17, 2026

About BZYR

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1977
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: BZYR

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 19, 2026

Data Sources Report a data error